Group One Trading’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Group One Trading’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16	Closed	-$63	–	8503
2023 Q3	$63	Sell	16 -1,002	-98%	-$6.84K	﹤0.01%	7496
2023 Q2	$3.31K	Buy	+1,018	New	+$3.03K	﹤0.01%	6894
2022 Q4	–	Sell	-554	Closed	-$23K	–	8367
2022 Q3	$23K	Sell	554 -588	-51%	-$26.9K	﹤0.01%	5990
2022 Q2	$48K	Sell	1,142 -21,505	-95%	-$997K	﹤0.01%	5599
2022 Q1	$1.53M	Buy	22,647 +16,332	+259%	+$1.36M	﹤0.01%	2669
2021 Q4	$767K	Buy	+6,315	New	+$1.07M	﹤0.01%	3628

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Group One Trading's EVLO Position: Q4 2023 in Review

Group One Trading sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 16 shares — an estimated $63 sold.

Group One Trading first reported a position in EVLO in Q4 2021 and held it in 6 quarters. The position peaked at $1.53M in Q1 2022. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Group One Trading reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 16 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $63.
Group One Trading first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Group One Trading's Evelo Biosciences, Inc. Common Stock position peaked at $1.53M in Q1 2022.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.